BioNxt Solutions (OTCMKTS:BNXTF) Announces Earnings Results

BioNxt Solutions (OTCMKTS:BNXTFGet Free Report) posted its earnings results on Wednesday. The company reported ($0.01) EPS for the quarter, Zacks reports.

BioNxt Solutions Stock Performance

Shares of BNXTF stock remained flat at $0.33 during trading hours on Friday. The stock had a trading volume of 2,200 shares, compared to its average volume of 2,565. The company has a market capitalization of $39.97 million, a price-to-earnings ratio of -8.16 and a beta of 0.87. The business’s fifty day moving average price is $0.40 and its 200 day moving average price is $0.46. BioNxt Solutions has a twelve month low of $0.26 and a twelve month high of $0.80.

BioNxt Solutions Company Profile

(Get Free Report)

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.

See Also

Earnings History for BioNxt Solutions (OTCMKTS:BNXTF)

Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.